[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SK284285B6 - Farmaceutická zmes obsahujúca spojenie aktívnych látok, v ktorom aktívne látky sú clopidogrel a aspirín, a použitie tejto zmesi na prípravu liečiva - Google Patents

Farmaceutická zmes obsahujúca spojenie aktívnych látok, v ktorom aktívne látky sú clopidogrel a aspirín, a použitie tejto zmesi na prípravu liečiva Download PDF

Info

Publication number
SK284285B6
SK284285B6 SK1105-98A SK110598A SK284285B6 SK 284285 B6 SK284285 B6 SK 284285B6 SK 110598 A SK110598 A SK 110598A SK 284285 B6 SK284285 B6 SK 284285B6
Authority
SK
Slovakia
Prior art keywords
aspirin
clopidogrel
pharmaceutical composition
administration
composition according
Prior art date
Application number
SK1105-98A
Other languages
English (en)
Slovak (sk)
Other versions
SK110598A3 (en
Inventor
Andr Bernat
Jean-Marc Herbert
Pierre Savi
Original Assignee
Sanofi-Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9489354&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK284285(B6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi-Synthelabo filed Critical Sanofi-Synthelabo
Publication of SK110598A3 publication Critical patent/SK110598A3/sk
Publication of SK284285B6 publication Critical patent/SK284285B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Materials For Medical Uses (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK1105-98A 1996-02-19 1997-02-17 Farmaceutická zmes obsahujúca spojenie aktívnych látok, v ktorom aktívne látky sú clopidogrel a aspirín, a použitie tejto zmesi na prípravu liečiva SK284285B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9602027A FR2744918B1 (fr) 1996-02-19 1996-02-19 Nouvelles associations de principes actifs contenant un derive de thieno(3,2-c)pyridine et un antithrombotique
PCT/FR1997/000296 WO1997029753A1 (fr) 1996-02-19 1997-02-17 Nouvelles associations de principes actifs contenant du clopidogrel et un antithrombotique

Publications (2)

Publication Number Publication Date
SK110598A3 SK110598A3 (en) 1999-01-11
SK284285B6 true SK284285B6 (sk) 2005-01-03

Family

ID=9489354

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1105-98A SK284285B6 (sk) 1996-02-19 1997-02-17 Farmaceutická zmes obsahujúca spojenie aktívnych látok, v ktorom aktívne látky sú clopidogrel a aspirín, a použitie tejto zmesi na prípravu liečiva

Country Status (29)

Country Link
US (1) US5989578A (cs)
EP (1) EP0881901B1 (cs)
JP (1) JP3662028B2 (cs)
KR (1) KR100295345B1 (cs)
CN (1) CN1116042C (cs)
AT (1) ATE218870T1 (cs)
AU (1) AU715655B2 (cs)
BR (1) BR9707556A (cs)
CA (1) CA2246289C (cs)
CZ (1) CZ292363B6 (cs)
DE (2) DE122010000030I2 (cs)
DK (1) DK0881901T3 (cs)
EE (1) EE03513B1 (cs)
ES (1) ES2176684T3 (cs)
FR (1) FR2744918B1 (cs)
HK (1) HK1017850A1 (cs)
HU (1) HU225036B1 (cs)
IL (1) IL125848A (cs)
IS (1) IS1892B (cs)
NO (2) NO317747B3 (cs)
NZ (1) NZ331444A (cs)
PL (1) PL187292B1 (cs)
PT (1) PT881901E (cs)
RU (1) RU2184547C2 (cs)
SI (1) SI0881901T1 (cs)
SK (1) SK284285B6 (cs)
TR (1) TR199801608T2 (cs)
UA (1) UA51695C2 (cs)
WO (1) WO1997029753A1 (cs)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2322824A1 (en) * 1998-03-13 1999-09-16 Merck & Co., Inc. Combination therapy and composition for acute coronary ischemic syndrome and related conditions
DE69926750T2 (de) 1998-06-17 2006-06-29 Bristol-Myers Squibb Co. Vorbeugung des hirninfarkts durch kombinierte verabreichung von adp-rezeptor antiblutplättchen und antihypertensiven medikamenten
US6509348B1 (en) 1998-11-03 2003-01-21 Bristol-Myers Squibb Company Combination of an ADP-receptor blocking antiplatelet drug and a thromboxane A2 receptor antagonist and a method for inhibiting thrombus formation employing such combination
FR2792836B3 (fr) 1999-04-30 2001-07-27 Sanofi Sa Composition pharmaceutique sous forme unitaire contenant de l'aspirine et de l'hydrogenosulfate de clopidogrel
FR2797400A1 (fr) * 1999-08-11 2001-02-16 Sanofi Synthelabo Associations a activite anti-thrombotique constituees de l'hydrogenosulfate de clopidogrel et d'un antagoniste des recepteurs gpiib/iiia et les compositions pharmaceutiques les contenant
CA2432644C (en) 2000-12-25 2013-07-23 Fumitoshi Asai Pharmaceutical composition comprising aspirintm and cs-747
SE0101932D0 (sv) * 2001-05-31 2001-05-31 Astrazeneca Ab Pharmaceutical combinations
FR2832929A1 (fr) * 2001-12-05 2003-06-06 Sanofi Synthelabo Compositions pharmaceutiques contenant un agent antithrombotique et un derive d'amines cycliques
US20040067995A1 (en) * 2002-10-02 2004-04-08 Wong Pancras C. Novel combination of a factor Xa inhibitor and clopidogrel
US20070243632A1 (en) * 2003-07-08 2007-10-18 Coller Barry S Methods for measuring platelet reactivity of patients that have received drug eluting stents
US7790362B2 (en) * 2003-07-08 2010-09-07 Accumetrics, Inc. Controlled platelet activation to monitor therapy of ADP antagonists
HUP0400982A2 (en) * 2004-05-17 2006-08-28 Chemor Kutato New veterinary product for honeybees
US20060222640A1 (en) * 2005-03-29 2006-10-05 Boehringer Ingelheim International Gmbh New pharmaceutical compositions for treatment of thrombosis
EP1926736A4 (en) * 2005-09-21 2010-08-25 Chong Kun Dang Pharm Corp NEW RESINATE COMPLEX OF S-CLOPIDOGREL AND METHOD FOR THE PRODUCTION THEREOF
WO2008048083A1 (es) * 2006-10-17 2008-04-24 Espinosa Abdala Leopoldo De Je Composiciones farmacéuticas para el tratamiento de enfermedades tromboembólicas
DE102006051625A1 (de) 2006-11-02 2008-05-08 Bayer Materialscience Ag Kombinationstherapie substituierter Oxazolidinone
CN101686681B (zh) 2007-04-27 2015-04-01 锡德克斯药物公司 包含氯吡格雷和磺基烷基醚环糊精的制剂和其使用方法
JP2011512406A (ja) * 2008-02-22 2011-04-21 ハナル バイオファーマ カンパニー リミテッド 複合製剤
DE102008032361A1 (de) 2008-07-10 2010-01-21 Csl Behring Gmbh Der Einsatz von Faktor VIII und vWF bzw. vWF-enthaltenden Konzentraten zur Therapie der durch Thrombocyten-Inhibitoren induzierte Koagulopathie
KR101991367B1 (ko) * 2009-05-13 2019-06-21 사이덱스 파마슈티칼스, 인크. 프라수그렐 및 사이클로덱스트린 유도체를 포함하는 약학 조성물 및 그의 제조 및 사용 방법
NZ597510A (en) 2009-06-25 2012-12-21 Tetra Sia NOVEL ACETYLSALICYLIC ACID SALTS, the salts are 4-trimethylammoniobutanoate, L-carnitine and meldonium
US8563574B2 (en) 2009-12-07 2013-10-22 Academic Pharmaceuticals, Inc. Parenteral formulation of clopidogrel
CN102389436A (zh) * 2011-09-09 2012-03-28 北京阜康仁生物制药科技有限公司 一种抗血小板聚集的药物组合物
KR101675501B1 (ko) * 2011-11-02 2016-11-14 한국유나이티드제약 주식회사 클로피도그렐 및 아스피린의 복합제제
US8513278B2 (en) 2011-11-26 2013-08-20 Academic Pharmaceuticals, Inc. Parenteral dextrose formulation of clopidogrel
CN102406938A (zh) * 2011-11-29 2012-04-11 北京阜康仁生物制药科技有限公司 一种抗血栓的药物组合物
WO2013133620A1 (en) * 2012-03-09 2013-09-12 Yuhan Corporation Pharmaceutical composition comprising clopidogrel and aspirin and process for preparing the same
CN103720700A (zh) * 2012-10-10 2014-04-16 江苏威凯尔医药科技有限公司 含有阿斯匹林和维卡格雷的药用组合物
EP2796145B1 (en) 2013-04-22 2017-11-01 CSL Ltd. A covalent complex of von willebrand factor and faktor viii linked by a disulphide bridge
KR101502588B1 (ko) 2013-05-01 2015-03-16 한국유나이티드제약 주식회사 클로피도그렐 및 아스피린의 복합제제
WO2015015062A1 (fr) * 2013-08-02 2015-02-05 Sanofi Comprime pharmaceutique comprenant de l'acide acetylsalicylique et du clopidogrel
HUP1400294A2 (hu) 2014-06-13 2015-12-28 Skillpharm Kft Clopidogrel új alkalmazása
CN107698620A (zh) 2015-06-23 2018-02-16 江苏天士力帝益药业有限公司 一种氘代噻吩并哌啶衍生物、制备方法及其应用
RU2745774C1 (ru) * 2020-08-14 2021-03-31 Алексей Викторович Марочков Способ лечения пациентов с новой коронавирусной инфекцией (covid-19)
WO2023012479A1 (en) 2021-08-03 2023-02-09 Liqmeds Worldwide Limited An oral pharmaceutical solution of clopidogrel

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2307538A1 (fr) * 1975-04-18 1976-11-12 Centre Etd Ind Pharma Nouveau medicament anti-agregant plaquettaire

Also Published As

Publication number Publication date
EP0881901B1 (fr) 2002-06-12
DE122010000030I2 (de) 2012-06-21
CN1116042C (zh) 2003-07-30
WO1997029753A1 (fr) 1997-08-21
CA2246289C (fr) 2003-12-16
KR100295345B1 (ko) 2001-08-07
ATE218870T1 (de) 2002-06-15
SK110598A3 (en) 1999-01-11
EE9800247A (et) 1999-02-15
NO317747B1 (no) 2004-12-13
AU1884497A (en) 1997-09-02
JPH11510818A (ja) 1999-09-21
PL327923A1 (en) 1999-01-04
EE03513B1 (et) 2001-10-15
CN1211922A (zh) 1999-03-24
HUP9901144A3 (en) 2001-04-28
TR199801608T2 (xx) 1998-11-23
DK0881901T3 (da) 2002-10-07
IS1892B (is) 2003-10-20
DE69713287D1 (de) 2002-07-18
NO2010015I2 (no) 2012-11-12
HUP9901144A2 (hu) 1999-09-28
IL125848A (en) 2000-11-21
RU2184547C2 (ru) 2002-07-10
NO983812D0 (no) 1998-08-19
UA51695C2 (uk) 2002-12-16
PL187292B1 (pl) 2004-06-30
ES2176684T3 (es) 2002-12-01
IS4827A (is) 1998-08-18
FR2744918A1 (fr) 1997-08-22
CZ249998A3 (cs) 1998-11-11
BR9707556A (pt) 1999-07-27
DE122010000030I1 (de) 2010-10-21
PT881901E (pt) 2002-09-30
NO983812L (no) 1998-10-09
CZ292363B6 (cs) 2003-09-17
HK1017850A1 (en) 1999-12-03
HU225036B1 (en) 2006-05-29
CA2246289A1 (fr) 1997-08-21
NO2010015I1 (no) 2010-07-26
US5989578A (en) 1999-11-23
NZ331444A (en) 2001-04-27
FR2744918B1 (fr) 1998-05-07
NO317747B3 (no) 2011-10-03
JP3662028B2 (ja) 2005-06-22
KR19990087163A (ko) 1999-12-15
EP0881901A1 (fr) 1998-12-09
IL125848A0 (en) 1999-04-11
AU715655B2 (en) 2000-02-10
DE69713287T2 (de) 2002-12-19
SI0881901T1 (en) 2002-10-31

Similar Documents

Publication Publication Date Title
SK284285B6 (sk) Farmaceutická zmes obsahujúca spojenie aktívnych látok, v ktorom aktívne látky sú clopidogrel a aspirín, a použitie tejto zmesi na prípravu liečiva
US5576328A (en) Method for the secondary prevention of ischemic events
KR100692934B1 (ko) 아스피린을 함유하는 의약 조성물
SK286311B6 (en) Use of an indirect inhibitor of factor Xa in combination with a compound with anti-platelet aggregation activity and pharmaceutical compositions comprising said agents
PL188739B1 (pl) Kompozycja farmaceutyczna oraz zastosowanie kombinacji pochodnej tienopirydyny i inhibitora reduktazy HMG-CoA
CZ283259B6 (cs) Použití //4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl) fenyl/hydrazono/-propandinitrilu nebo jeho farmaceuticky vhodných solí k výrobě léčiva
HU193793B (en) Process for producing pharmaceutical compositions containing pyrimido-pyrimidines and o-acetyl-salicylic acid or pharmaceutically acceptable salts thereof
CA2199642C (en) Compositions containing an association of aspirin and an anti-xa oligosaccharide and use of an anti-xa oligosaccharide optionally in combination with aspirin
US20060122151A1 (en) Composition containing an association of aspirin and an anti-Xa oligosaccharide and use of an anti-Xa oligosaccharide optionally in combination with aspirin
MXPA97001943A (en) Compositions containing an acetilsalicilic acid association and an anti-xa oligosacarid and use of an anti-xa oligosacaride optionally in combination with acetilsalicil acid
WO2001012198A1 (fr) Medicaments diriges contre l'infarctus du myocarde

Legal Events

Date Code Title Description
MC4A Annulment of patent

Effective date: 20130603